Search | IOVS | ARVO Journals

View

Showing 1 – 18 of 18

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract March 2012

Focal Choroidal Edema (FCE) - Activity Sign Of Or Prior To Chorodial Neovascularizations Secondary To Pathologic Myopia?

Focke Ziemssen; Werner Inhoffen; Michael Voelker; Karl Ulrich Bartz-Schmidt

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4439. doi:

ARVO Annual Meeting Abstract April 2010

Intravitreal Bevacizumab Monotherapy for Retinal Angiomatous Proliferation: One- and Two Year Results

F. Gelisken; M. Voelker; W. Inhoffen; K. U. Bartz-Schmidt; F. Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):904. doi:

ARVO Annual Meeting Abstract April 2009

Intravitreal Bevacizumab for Choroidal Neovascularisation in Pathological Myopia: 2-Years Results

B. Voykov; F. Ziemssen; M. Voelker; W. Inhoffen; K. Bartz-Schmidt; F. Gelisken

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2281. doi:

ARVO Annual Meeting Abstract April 2009

Long-Term Follow-Up of Intravitreal Bevacizumab in Serous Retinal Pigment Epithelial Detachment

F. Ziemssen; F. Gelisken; M. Voelker; W. Inhoffen; S. Grisanti; K. U. Bartz-Schmidt

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):5002. doi:

ARVO Annual Meeting Abstract May 2008

Long-Term Follow-Up of Circumscribed Choroidal Haemangioma With Acute Exsudative Retinal Detachment Following Single Verteporfin Photodynamic Therapy

M. Volker; W. Inhoffen; F. Gelisken; K. Bartz-Schmidt

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5687. doi:

ARVO Annual Meeting Abstract May 2008

Intravitreal Bevacizumab Treatment for Retinal Angiomatous Proliferation: One Year Results

F. Gelisken; E. Altpeter; F. Ziemssen; M. Völker; W. Inhoffen; K. U. Bartz-Schmidt

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):274. doi:

ARVO Annual Meeting Abstract May 2008

Intravitreal Bevacizumab for Neovascular Age-Related Macular Degeneration: 12 Months Results

B. Voykov; F. Ziemssen; M. Voelker; W. Inhoffen; K. U. Bartz-Schmidt; F. Gelisken

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):275. doi:

ARVO Annual Meeting Abstract May 2008

Morphological Outcome of Intravitreal Bevacizumab Treatment for Neovascular AMD: 12-Month Follow-Up of Optical Coherence Tomography

F. Ziemssen; B. Voykov; F. Gelisken; M. Leitritz; M. Völker; W. Inhoffen; K. U. Bartz-Schmidt

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):333. doi:

ARVO Annual Meeting Abstract May 2007

Intravitreous Bevacizumab Monotherapy vs. Combined Therapy (Bevacizumab + PDT) of Choroidal Neovascularization in Pathological Myopia: Outcome and Re-Treatment

F. Ziemssen; W. Inhoffen; M. Voelcker; S. Grisanti; P. Szurman; K. U. Bartz-Schmidt; Tuebingen Bevacizumab Study Group; F. Gelisken

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):3397. doi:

ARVO Annual Meeting Abstract May 2006

Analysis of Functional and Morphological Outcomes of Full Macular Translocation Prior and Following to Photodynamic Therapy in Neovascular Age–Related Macular Degeneration

D. Suesskind; F. Gelisken; M. Voelker; W. Inhoffen; M. Partsch; S. Grisanti; K. Bartz–Schmidt

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):354. doi:

ARVO Annual Meeting Abstract May 2006

Confocal Scanning Laser Tomography of the Disc after Intravitreous Triamcinolone Acetonide (Volon A)

M.A. Leitritz; W. Inhoffen; M. Voelker; F. Ziemssen; K.–U. Bartz–Schmidt

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):4267. doi:

ARVO Annual Meeting Abstract May 2005

Contrast Sensitivity Following Macular Translocation With 360° Retinotomy for Neovascular Age–Related Macular Degeneration

F. Ziemssen; F. Gelisken; M. Partsch; S. Grisanti; M. Warga; K. Karim–Zoda; W. Inhoffen; K.–U. Bartz–Schmidt

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):211. doi:

ARVO Annual Meeting Abstract May 2004

Immunohistopathologic Evaluation Of Choroidal Neovascular Membranes Following Verteporfin–photodynamic Therapy

O. Tatar; S. Grisanti; F. Gelisken; W. Inhoffen; P. Szurman; S. Aisenbrey; K.U. Bartz–Schmidt

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):1781. doi:

ARVO Annual Meeting Abstract May 2004

Analysis of Recurrent Choroidal Neovascularization after Macular Translocation with 360° Retinotomy for Neovascular Age–related Macular Degeneration

F. Ziemssen; F. Gelisken; S. Grisanti; W. Inhoffen; K.–U. Bartz–Schmidt

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2002. doi:

ARVO Annual Meeting Abstract May 2004

A new SLO microperimetry using gaze–contingent stimulus placement

J. Reinhard; W. Inhoffen; S. Trauzettel–Klosinski

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2993. doi:

ARVO Annual Meeting Abstract May 2003

Functional and Morphological Outcomes after Verteporfin Photodynamic Therapy (PDT) for Circumscribed Chorioidal Haemangioma (CCH)

M. Völker; W. Inhoffen; F. Gelisken; K.U. Bartz-Schmidt

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):1587. doi:

ARVO Annual Meeting Abstract December 2002

Histopathologic Findings of Surgically Excised Choroidal Neovascularization Three Days Following Photodynamic Therapy in Age-related Macular Degeneration

F Gelisken; B Lafaut; W Inhoffen; M Voelker; S Grisanti; KU Bartz-Schmidt

Invest. Ophthalmol. Vis. Sci.. 2002; 43(13):587. doi:

ARVO Annual Meeting Abstract December 2002

Implantation of Microphotodiode Arrays (MPDA) in Cats: OCT and Fluorescein Angiography

M Volker; F Gekeler; K Shinoda; HG Sachs; H Gmeiner; K Kohler; W Inhoffen; KU Bartz-Schmidt; E Zrenner

Invest. Ophthalmol. Vis. Sci.. 2002; 43(13):4455. doi:

Advertisement